Zolpidem Tartrate Tablet, Film Coated, Extended Release
Product Images NDC 71335-1468

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71335-1468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Zolpidem Tartrate depicting the molecular arrangement of the active ingredient, including aromatic rings, nitrogen atoms, and the tartrate moiety.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing mean plasma concentration-time profiles of Zolpidem Tartrate extended-release tablets (12.5 mg) and immediate-release tablets (10 mg). The x-axis shows time in hours, and the y-axis shows zolpidem plasma concentrations in ng/mL. Curves illustrate plasma levels rising and declining over 8 hours for both formulations.*

FDA Label Image

Label Image (Lbl713351468)

Label for Zolpidem ER 12.5 mg extended release tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates yellow/white round tablets, compares to Ambien CR 12.5 mg by Sun Pharma Ind. Ltd, contains a 30 count, and includes storage instructions at 20°-25°C. The NDC is 71335-1468-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.